Linking obesogenic dysregulation to prostate cancer progression.
about
Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenografts.Diffuse Optical Spectroscopy and Imaging to Detect and Quantify Adipose Tissue Browning.Adiponectin as a Potential Therapeutic Target for Prostate Cancer.Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease.Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathways
P2860
Linking obesogenic dysregulation to prostate cancer progression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Linking obesogenic dysregulation to prostate cancer progression.
@ast
Linking obesogenic dysregulation to prostate cancer progression.
@en
type
label
Linking obesogenic dysregulation to prostate cancer progression.
@ast
Linking obesogenic dysregulation to prostate cancer progression.
@en
prefLabel
Linking obesogenic dysregulation to prostate cancer progression.
@ast
Linking obesogenic dysregulation to prostate cancer progression.
@en
P2093
P2860
P356
P1476
Linking obesogenic dysregulation to prostate cancer progression.
@en
P2093
Jennifer Lo
Matthew J Watt
Natasha Ascui
Renea A Taylor
P2860
P304
P356
10.1530/EC-15-0080
P577
2015-12-01T00:00:00Z